1. Home
  2. BYND vs TVRD Comparison

BYND vs TVRD Comparison

Compare BYND & TVRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYND
  • TVRD
  • Stock Information
  • Founded
  • BYND 2009
  • TVRD 2017
  • Country
  • BYND United States
  • TVRD United States
  • Employees
  • BYND N/A
  • TVRD N/A
  • Industry
  • BYND Packaged Foods
  • TVRD Biotechnology: Pharmaceutical Preparations
  • Sector
  • BYND Consumer Staples
  • TVRD Health Care
  • Exchange
  • BYND Nasdaq
  • TVRD Nasdaq
  • Market Cap
  • BYND 214.6M
  • TVRD 246.5M
  • IPO Year
  • BYND 2019
  • TVRD N/A
  • Fundamental
  • Price
  • BYND $2.12
  • TVRD $5.01
  • Analyst Decision
  • BYND Sell
  • TVRD Buy
  • Analyst Count
  • BYND 7
  • TVRD 7
  • Target Price
  • BYND $2.08
  • TVRD $51.67
  • AVG Volume (30 Days)
  • BYND 397.9M
  • TVRD 652.1K
  • Earning Date
  • BYND 11-04-2025
  • TVRD 11-21-2025
  • Dividend Yield
  • BYND N/A
  • TVRD N/A
  • EPS Growth
  • BYND N/A
  • TVRD N/A
  • EPS
  • BYND N/A
  • TVRD N/A
  • Revenue
  • BYND $301,353,000.00
  • TVRD N/A
  • Revenue This Year
  • BYND N/A
  • TVRD N/A
  • Revenue Next Year
  • BYND $0.73
  • TVRD N/A
  • P/E Ratio
  • BYND N/A
  • TVRD N/A
  • Revenue Growth
  • BYND N/A
  • TVRD N/A
  • 52 Week Low
  • BYND $0.50
  • TVRD $4.90
  • 52 Week High
  • BYND $7.69
  • TVRD $43.65
  • Technical
  • Relative Strength Index (RSI)
  • BYND 50.39
  • TVRD 19.92
  • Support Level
  • BYND $0.50
  • TVRD $5.65
  • Resistance Level
  • BYND $7.69
  • TVRD $7.23
  • Average True Range (ATR)
  • BYND 0.82
  • TVRD 1.17
  • MACD
  • BYND 0.18
  • TVRD -2.25
  • Stochastic Oscillator
  • BYND 23.78
  • TVRD 0.25

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

About TVRD Tvardi Therapeutics Inc. Common Stock

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.

Share on Social Networks: